updated 9/14/2007 10:44:36 AM ET 2007-09-14T14:44:36

The deaths of two patients prescribed a powerful painkiller as a headache treatment were among four fatalities linked to the recently approved drug, its manufacturer reported Thursday.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

All four deaths apparently involved improper use of the drug, called Fentora, manufacturer Cephalon Inc. said. The Food and Drug Administration was monitoring the situation, a spokeswoman said.

The FDA approved the drug in September for use only by cancer patients already taking morphine or other prescription narcotics for their pain. Fentora contains fentanyl, which is similar to morphine, but far more potent.

Besides the two headache patients, the other deaths involved a suicide and a patient administered the drug outside the recommended dosing.

"None of the reports were in cancer patients, which leads us to believe they were inappropriate candidates for the product," Cephalon spokeswoman Candace Steele said.

Cephalon reminded doctors and pharmacists, in letters dated Monday but released Thursday by the FDA, of who should take the drug, and in what quantities and how often. The company also warned not to substitute Fentora on a one-for-one basis for another, older fentanyl drug called Actiq that it also makes, because the newer drug is stronger.

"The FDA takes this very seriously, and is working with the company to assure the safest possible use of this medication," agency spokeswoman Susan Cruzan said.

Steele said the deaths were not linked to allegations subject to investigation that Cephalon engaged in improper promotion of Fentora and other drugs for uses other than those outlined in their FDA-approved labels. While it's not illegal for doctors to prescribe drugs for so-called "off-label" uses, companies are prohibited from marketing medicines for those purposes.

Last month, Frazer, Pa.-based Cephalon said it was cooperating with the investigations by Congress, the U.S. attorney's office in Philadelphia and Connecticut attorney general.

Doctors have written about 78,000 prescriptions for Fentora tablets since October, Steele said.

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments